Mitral Valve Prolapse: Multimedia

References

1. Freed LA, Levy D, Levine RA, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med. Jul 1 1999;341(1):1-7. [Medline].

2. Avierinos JF, Brown RD, Foley DA. Cerebral ischemic events after diagnosis of mitral valve prolapse: a community-based study of incidence and predictive factors. Stroke. Jun 2003;34(6):1339-44. [Medline].

3. Singh RG, Cappucci R, Kramer-Fox R, et al. Severe mitral regurgitation due to mitral valve prolapse: risk factors for development, progression, and need for mitral valve surgery. Am J Cardiol. Jan 15 2000;85(2):193-8. [Medline].

4. Chou HT, Shi YR, Hsu Y. Association between fibrillin-1 gene exon 15 and 27 polymorphisms and risk of mitral valve prolapse. J Heart Valve Dis. Jul 2003;12(4):475-81. [Medline].

5. Lichodziejewska B, Klos J, Rezler J, et al. Clinical symptoms of mitral valve prolapse are related to hypomagnesemia and attenuated by magnesium supplementation. Am J Cardiol. Mar 15 1997;79(6):768-72. [Medline].

6. Scordo KA. Mitral valve prolapse syndrome: interventions for symptom control. Dimens Crit Care Nurs. Jul-Aug 1998;17(4):177-86. [Medline].

7. Fontana ME, Sparks EA, Boudoulas H, Wooley CF. Mitral valve prolapse and the mitral valve prolapse syndrome. Curr Probl Cardiol. May 1991;16(5):309-75. [Medline].

8. Kao CH, Tsai SC, Hsieh JF, et al. Radionuclide esophageal transit test to detect esophageal disorders in patients with mitral valve prolapse. Nuklearmedizin. 2000;39(4):92-6. [Medline].

9. Theal M, Sleik K, Anand S. Prevalence of mitral valve prolapse in ethnic groups. Can J Cardiol. Apr 2004;20(5):511-5. [Medline].

10. Devereux RB, Kramer-Fox R, Kligfield P. Mitral valve prolapse: causes, clinical manifestations, and management. Ann Intern Med. Aug 15 1989;111(4):305-17. [Medline].

11. Tamam L, Ozpoyraz N, San M, Bozkurt A. Association between idiopathic mitral valve prolapse and panic disorder. Croat Med J. Dec 2000;41(4):410-6. [Medline].

12. Raggi P, Callister TQ, Lippolis NJ, Russo DJ. Is mitral valve prolapse due to cardiac entrapment in the chest Cavity? A CT view. Chest. Mar 2000;117(3):636-42. [Medline].

13. Han L, Ho TF, Yip WC, Chan KY. Heart rate variability of children with mitral valve prolapse. J Electrocardiol. Jul 2000;33(3):219-24. [Medline].

14. Kochiadakis GE, Parthenakis FI, Zuridakis EG, et al. Is there increased sympathetic activity in patients with mitral valve prolapse?. Pacing Clin Electrophysiol. Nov 1996;19(11 Pt 2):1872-6. [Medline].

15. Freed LA, Acierno JS, Dai D. A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4. Am J Hum Genet. Jun 2003;72(6):1551-9. [Medline].

16. Ozkan M, Kaymaz C, Dinckal H, et al. Single-photon emission computed tomographic myocardial perfusion imaging in patients with mitral valve prolapse. Am J Cardiol. Feb 15 2000;85(4):516-8, A11. [Medline].

17. Salem DN, O'Gara PT, Madias C, Pauker SG. Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. Jun 2008;133(6 Suppl):593S-629S. [Medline].

18. Karakurum B, Topcu S, Yildirim T. Silent cerebral infarct in patients with mitral valve prolapse. Int J Neurosci. Nov 2005;115(11):1527-37. [Medline].

19. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. Oct 9 2007;116(15):1736-54. [Medline].

20. Gould FK, Elliott TS, Foweraker J. Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother. Jun 2006;57(6):1035-42. [Medline].

21. Berbarie RF, Roberts WC. Frequency of atrial fibrillation in patients having mitral valve repair or replacement for pure mitral regurgitation secondary to mitral valve prolapse. Am J Cardiol. Apr 1 2006;97(7):1039-44. [Medline].

22. Avierinos JF, Gersh BJ, Melton LJ. Natural history of asymptomatic mitral valve prolapse in the community. Circulation. Sep 10 2002;106(11):1355-61. [Medline].

23. Bobkowski W, Siwinska A, Zachwieja J. A prospective study to determine the significance of ventricular late potentials in children with mitral valvar prolapse. Cardiol Young. Jul 2002;12(4):333-8. [Medline].

24. Bonow RO, Carabello B, de Leon AC, et al. ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Val. J Heart Valve Dis. Nov 1998;7(6):672-707. [Medline].

25. Freed LA, Benjamin EJ, Levy D. Mitral valve prolapse in the general population: the benign nature of echocardiographic features in the Framingham Heart Study. J Am Coll Cardiol. Oct 2 2002;40(7):1298-304. [Medline].

26. Gilon D, Buonanno FS, Joffe MM, et al. Lack of evidence of an association between mitral-valve prolapse and stroke in young patients. N Engl J Med. Jul 1 1999;341(1):8-13. [Medline].

27. Kitlinski M, Stepniewski M, Nessler J. Is magnesium deficit in lymphocytes a part of the mitral valve prolapse syndrome?. Magnes Res. Mar 2004;17(1):39-45. [Medline].

28. La Vecchia L, Ometto R, Centofante P, et al. Arrhythmic profile, ventricular function, and histomorphometric findings in patients with idiopathic ventricular tachycardia and mitral valve prolapse: clinical and prognostic evaluation. Clin Cardiol. Oct 1998;21(10):731-5. [Medline].

29. Leung DY, Dawson IG, Thomas JD, Marwick TH. Accuracy and cost-effectiveness of exercise echocardiography for detection of coronary artery disease in patients with mitral valve prolapse. Am Heart J. Dec 1997;134(6):1052-7. [Medline].

Further Reading

Keywords

mitral valve prolapse, MVP, endocarditis, bacterial endocarditis, stroke, mitral valve surgery, sudden death, supraventricular arrhythmias, palpitations, mitral regurgitation, MR, syncope, Marfan syndrome, polyarteritis nodosa, relapsing polychondritis, systemic lupus erythematosus, Stickler syndrome, pseudoxanthoma elasticum, osteogenesis imperfecta, Ehlers-Danlos syndrome type I, Ehlers-Danlos syndrome type II, Ehlers-Danlos syndrome type IV, polycystic kidney disease, Duchenne muscular dystrophy, fragile X syndrome, mucopolysaccharidoses, myotonic dystrophy, atrial septal defect, Ebstein anomaly, papillary muscle dysfunction, cardiac trauma, post mitral valve surgery, rheumatic endocarditis, Wolff-Parkinson-White syndrome, Von Willebrand disease

Contributor Information and Disclosures

Author

Michael C Plewa, MD, Research Coordinator, Consulting Staff, Department of Emergency Medicine, Lucas County Emergency Physicians, Inc, and Saint Vincent Mercy Medical Center
Michael C Plewa, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, Physicians for Social Responsibility, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Richard Worthington, MD, Assistant Clinical Professor, Program Instructor, Department of Emergency Medicine, St Vincent Mercy Medical Center
Richard Worthington, MD is a member of the following medical societies: American College of Emergency Physicians, Ohio State Medical Association, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Medical Editor

Robert M McNamara, MD, FAAEM, Chair and Professor, Department of Emergency Medicine, Temple University School of Medicine
Robert M McNamara, MD, FAAEM is a member of the following medical societies: American Academy of Emergency Medicine, American Medical Association, Pennsylvania Medical Society, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Paul Blackburn, DO, FACOEP, FACEP, Program Director, Department of Emergency Medicine, Maricopa Medical Center; Assistant Professor, Department of Surgery, University of Arizona
Paul Blackburn, DO, FACOEP, FACEP is a member of the following medical societies: American College of Emergency Physicians, American College of Osteopathic Emergency Physicians, American Medical Association, and Arizona Medical Association
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

David FM Brown, MD, Assistant Professor, Department of Medicine, Division of Emergency Medicine, Harvard Medical School; Associate-Chief, Attending Physician, Department of Emergency Medicine, Massachusetts General Hospital
David FM Brown, MD is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine
Disclosure: Schering  Honoraria Speaking and teaching